4-Hydroxy-5,6-dihydropyrones. 2. Potent Non-Peptide Inhibitors of HIV Protease
Bradley D. Tait(Pfizer (United States)), Beishan Liu, Sergei Gulnik(Beckman Coulter Foundation), Harriet W. Hamilton(Pfizer (United States)), A.G. Pavlovsky(Pfizer (United States)), Christopher Gajda(Pfizer (United States)), Susan E. Hagen(Pfizer (United States)), Elizabeth A. Lunney(Pfizer (United States)), Edmund L. Ellsworth(Pfizer (United States)), Peter J. Tummino(Intarcia Therapeutics (United States)), Christine Humblet(Pfizer (United States)), Carolyn Nouhan(Pfizer (United States)), Neil M.H. Graham(UK Dementia Research Institute), Eric T. Baldwin(Unknown), Talapady N. Bhat(National Institute of Standards and Technology), Donna Ferguson(Pfizer (United States)), Donald Hupe(Pfizer (United States)), John R. Rubin(Pfizer (United States)), J. V. N. Vara Prasad(Pfizer (United States)), Stephen J. Gracheck(Pfizer (United States)), John M. Domagala(Pfizer (United States)), John W. Erickson(National Institutes of Health)
Cited by 49
Related Papers
The Protein Data Bank
|Acta Crystallographica Section D Biological Crystallography|2002|2.6k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k